CLAIM CARD
The cited receipts show an apparent collision between a positive direct signal in general population (analytical studies) (vitamin D supplementation has a protective effect against the incidence of COVID-19 in analytical studies (OR = 0.592, 95% IC 0.476-0.736)) and an opposing endpoint in adults with chronic liver diseases (We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to
Evidence grade: exploratory
Contradiction status: none
Publication: e2acb093-79b1-4513-8106-e291ece5791d
Provenance: Derivation Web chain
Citation Support
source_1Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysissource_2Vitamin D supplementation for chronic liver diseases in adultssource_3Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Reviewsource_4Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseasessource_5Vitamin D and Lung Outcomes in Elderly COVID-19 Patients